Good Participatory Practice Guidelines for Biomedical HIV Prevention Trials

Good Participatory Practice Guidelines for Biomedical HIV Prevention Trials

The good participatory practice (GPP) guidelines are intended to provide trial funders, sponsors, and implementers with systematic guidance on how to effectively engage with all stakeholders in the design and conduct of biomedical HIV prevention trials.

For more information visit www.avac.org/gpp.